Financing

Proceeds from Issuance of Commercial Paper

Over 2 years (FY 2021 to FY 2024), Proceeds from Issuance of Commercial Paper shows a downward trend with a -100.0% CAGR.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2015
Last reportedQ1 2026May 1, 2026

How to read this metric

Frequent or increasing issuance may signal a need for short-term liquidity, while consistent use indicates efficient management of working capital cycles.

Detailed definition

This represents cash raised through the issuance of short-term, unsecured promissory notes used to manage immediate work...

Peer comparison

Standard for large-cap companies with high credit ratings that utilize commercial paper markets for low-cost, short-term financing.

Metric ID: financing_proceeds_from_issuance_of_commercial_paper

Historical Data

15 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q1 '26
Value$0.00$0.00$2.51B$626.00M$406.00M$199.00M$295.00M$1.03B$593.00M$0.00$0.00$0.00$0.00$0.00$389.00M
QoQ Change-75.1%-35.1%-51.0%+48.2%+248.1%-42.3%-100.0%
YoY Change-88.3%+64.1%+46.1%-100.0%-100.0%
Range$0.00$2.51B
Avg YoY Growth-35.6%
Median YoY Growth-88.3%

Frequently Asked Questions

What is Thermo Fisher Scientific's proceeds from issuance of commercial paper?
Thermo Fisher Scientific (TMO) reported proceeds from issuance of commercial paper of $389.00M in Q1 2026.
What is the long-term trend for Thermo Fisher Scientific's proceeds from issuance of commercial paper?
Over 2 years (2021 to 2024), Thermo Fisher Scientific's proceeds from issuance of commercial paper has grown at a -100.0% compound annual growth rate (CAGR), from $2.51B to $0.00.
What does proceeds from issuance of commercial paper mean?
Cash received from issuing short-term debt instruments to cover immediate funding needs.